Mission

ICER's mission is to lead innovation in comparative effectiveness research through methods that integrate considerations of clinical benefit and economic value.  Through a unique collaboration with patients, clinicians, manufacturers, insurers and other healthcare stakeholders, ICER develops tools to support patient decisions and medical policy that share the goal of achieving maximum value for every healthcare dollar.

Staff Only

Remember Me
TwitterLinkedinFacebookFeed
Support
ICER’s academic mission is funded through a diverse combination of sources; funding is not accepted from manufacturers or private insurers to perform reviews of specific technologies. Since its inception, ICER has received funding from the following sources:
 
  • Aetna Foundation
  • The Agency for Healthcare Research & Quality (AHRQ)
  • America’s Health Insurance Plans (AHIP)
  • Amgen
  • Blue Cross Blue Shield of Massachusetts
  • Blue Shield of California Foundation
  • Greater Boston Chamber of Commerce
  • Harvard Pilgrim Health Care
  • HealthPartners
  • The John W. Rowe Family Foundation
  • Johnson & Johnson
  • Kaiser Permanente
  • Merck & Co.
  • The National Pharmaceutical Council
  • Philips Healthcare
  • United Health Foundation
  • The Washington State Health Care Authority